Reducing the global breast cancer burden: the importance of patterns of care research.

Breast cancer treatment guidelines are not uniformly followed in clinical practice, with evidence for substantial variations in treatment patterns, quality of care, and patient outcomes among and within countries. The factors that drive treatment decisions are unclear. Furthermore, the impact of different treatment strategies on survival is poorly understood outside the clinical trial setting. Sources of patterns of care information often have limitations in completeness, quality, timeliness of reporting, and relevance to the larger population. Patterns of care studies frequently lack details on cancer stage at diagnosis, tumor biology, and treatment received. It is difficult to compare data between studies and/or track changes over time because of variations in data sources and collection techniques. Thus, the design and implementation of a global registry is sorely needed in order to prospectively evaluate worldwide patterns of care and outcomes in patients with breast cancer. Components of this registry should include random selection of centers of variable practice settings in multiple countries and accurate and rapid data reporting at prestudy and follow-up timepoints. Data collected would include tumor and demographic factors, staging information, treatment rendered, and survival. Variables that influenced the treatment selected would be assessed. This unique international effort would allow the development of strategies to improve diagnostic and treatment-related standards of care and survival outcomes, thus reducing the breast cancer burden worldwide.

[1]  M. Clarke Ovarian ablation for early breast cancer. , 2008, The Cochrane database of systematic reviews.

[2]  M. Rivard,et al.  Compliance with consensus recommendations for systemic therapy is associated with improved survival of women with node-negative breast cancer. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  R. Silliman Crossing the quality chasm in breast cancer care. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  C. Gillis,et al.  Why does specialist treatment of breast cancer improve survival? The role of surgical management , 2004, British Journal of Cancer.

[5]  H. D. de Koning,et al.  Trends in the usage of adjuvant systemic therapy for breast cancer in the Netherlands and its effect on mortality , 2004, British Journal of Cancer.

[6]  Ahmedin Jemal,et al.  Cancer Disparities by Race/Ethnicity and Socioeconomic Status , 2004, CA: a cancer journal for clinicians.

[7]  B. Bloom,et al.  Breast cancer treatment in clinical practice compared to best evidence and practice guidelines , 2004, British Journal of Cancer.

[8]  L. Richardson Treatment of Breast Cancer in Medically Underserved Women: A Review , 2004, The breast journal.

[9]  Ahmedin Jemal,et al.  Trends in Breast Cancer by Race and Ethnicity , 2003, CA: a cancer journal for clinicians.

[10]  M. Coleman,et al.  Stage at diagnosis is a key explanation of differences in breast cancer survival across Europe , 2003, International journal of cancer.

[11]  R. Gelber,et al.  Systemic treatments for women with breast cancer: outcome with relation to screening for the disease. , 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

[12]  F. Bray,et al.  Breast cancer incidence and mortality trends in 16 European countries. , 2003, European journal of cancer.

[13]  A. Goldhirsch,et al.  Adjuvant systemic therapies in women with breast cancer: an audit of clinical practice in Italy. , 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

[14]  A. DeMichele,et al.  Older age predicts a decline in adjuvant chemotherapy recommendations for patients with breast carcinoma , 2003, Cancer.

[15]  L. Tabár,et al.  Mammography service screening and mortality in breast cancer patients: 20-year follow-up before and after introduction of screening , 2003, The Lancet.

[16]  N. Bickell,et al.  Physicians’ Reasons for Failing to Deliver Effective Breast Cancer Care: A Framework for Underuse , 2003, Medical care.

[17]  T. Pajak,et al.  Compliance with breast‐conservation standards for patients with early‐stage breast carcinoma , 2003, Cancer.

[18]  Xianglin L. Du,et al.  Discrepancy between Consensus Recommendations and Actual Community Use of Adjuvant Chemotherapy in Women with Breast Cancer , 2003, Annals of Internal Medicine.

[19]  E. Feuer,et al.  Trends in use of adjuvant multi-agent chemotherapy and tamoxifen for breast cancer in the United States: 1975-1999. , 2002, Journal of the National Cancer Institute.

[20]  R. Brook,et al.  Quality of breast cancer care: what do we know? , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  K. Kahn,et al.  The case identification challenge in measuring quality of cancer care. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  G. Parrinello,et al.  Are International Guidelines for the Prescription of Adjuvant Treatment for Early Breast Cancer Followed in Clinical Practice? Results of a Population-Based Study on 1547 Patients , 2002, Tumori.

[23]  Sue A Joslyn,et al.  Racial differences in treatment and survival from early‐stage breast carcinoma , 2002, Cancer.

[24]  Beth A Virnig,et al.  Utility of the SEER-Medicare Data to Identify Chemotherapy Use , 2002, Medical care.

[25]  K. Kahn,et al.  Developing a Reliable, Valid, and Feasible Plan for Quality-of-Care Measurement for Cancer: How Should We Measure? , 2002, Medical care.

[26]  Colin B Begg,et al.  Survival of blacks and whites after a cancer diagnosis. , 2002, JAMA.

[27]  Cathy J Bradley,et al.  Race, socioeconomic status, and breast cancer treatment and survival. , 2002, Journal of the National Cancer Institute.

[28]  L. Clegg,et al.  Adjuvant therapy for breast cancer: practice patterns of community physicians. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[29]  Ingvar Andersson,et al.  Long-term effects of mammography screening: updated overview of the Swedish randomised trials , 2002, The Lancet.

[30]  V. Shavers,et al.  Racial and ethnic disparities in the receipt of cancer treatment. , 2002, Journal of the National Cancer Institute.

[31]  R. Gelber,et al.  Meeting highlights: international consensus panel on the treatment of primary breast cancer. , 2002, Journal of the National Cancer Institute.

[32]  D. Miles,et al.  Variations in treatment and survival in breast cancer. , 2001, The Lancet. Oncology.

[33]  Jeffrey N. Jonkman,et al.  Identifying a Cohort of Patients With Early-Stage Breast Cancer: A Comparison of Hospital Discharge and Primary Data , 2001, Medical care.

[34]  M. Sant Differences in stage and therapy for breast cancer across Europe , 2001, International journal of cancer.

[35]  R. Gelber,et al.  Meeting highlights: International Consensus Panel on the Treatment of Primary Breast Cancer. Seventh International Conference on Adjuvant Therapy of Primary Breast Cancer. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[36]  G. Budd,et al.  Delivering adjuvant chemotherapy to women with early‐stage breast carcinoma , 2001, Cancer.

[37]  J F Wilson,et al.  Factors predicting the use of breast-conserving therapy in stage I and II breast carcinoma. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[38]  J. Goodwin,et al.  Patterns of use of chemotherapy for breast cancer in older women: findings from Medicare claims data. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[39]  T. Key,et al.  Epidemiology of breast cancer. , 2001, The Lancet. Oncology.

[40]  M. Chassin,et al.  The Quality of Early-Stage Breast Cancer Care , 2000, Annals of surgery.

[41]  J. Brisson,et al.  Variations in the treatment of early-stage breast cancer in Quebec between 1988 and 1994. , 1999, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[42]  E. White,et al.  Breast conservation therapy in the United States following the 1990 National Institutes of Health Consensus Development Conference on the treatment of patients with early stage invasive breast carcinoma , 1999, Cancer.

[43]  J. Brisson,et al.  Time trends in systemic adjuvant treatment for node-negative breast cancer. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[44]  J. Brisson,et al.  Compliance with consensus recommendations for the treatment of early stage breast carcinoma in elderly women , 1999, Cancer.

[45]  F. Berrino,et al.  Variations in survival from breast cancer in Europe by age and country, 1978-1989. EUROCARE Working Group. , 1998, European journal of cancer.

[46]  Daniel S. Miller,et al.  Cancer surveillance in the U.S. , 1998, Cancer.

[47]  F. Berrino,et al.  Survival of women with breast cancer in Europe: Variation with age, year of diagnosis and country , 1998, International journal of cancer.

[48]  J. Gurwitz,et al.  The quality of care for treatment of early stage breast carcinoma , 1998, Cancer.

[49]  M S Swanson,et al.  Influence of socioeconomic and cultural factors on racial differences in late-stage presentation of breast cancer. , 1998, JAMA.

[50]  S. Coughlin,et al.  Mammography Use Helps To Explain Differences in Breast Cancer Stage at Diagnosis between Older Black and White Women , 1998, Annals of Internal Medicine.

[51]  A. Taylor-Vaisey,et al.  Translating guidelines into practice. A systematic review of theoretic concepts, practical experience and research evidence in the adoption of clinical practice guidelines. , 1997, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[52]  M. Schapira,et al.  Generalizability of the surveillance, epidemiology, and end results registry population: factors relevant to epidemiologic and health care research. , 1997, Journal of clinical epidemiology.

[53]  C. Redmond,et al.  Prognosis among African‐American women and white women with lymph node negative breast carcinoma , 1997, Cancer.

[54]  R. Weichselbaum,et al.  Race and clinical outcome in breast cancer in a series with long-term follow-up evaluation. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[55]  P. Craft,et al.  Surgical management of breast cancer in Australian women in 1993: analysis of Medicare statistics , 1997, The Medical journal of Australia.

[56]  K C Carriere,et al.  Information needs and decisional preferences in women with breast cancer. , 1997, JAMA.

[57]  S. Martino,et al.  Influence of patient characteristics, socioeconomic factors, geography, and systemic risk on the use of breast-sparing treatment in women enrolled in adjuvant breast cancer studies: an analysis of two intergroup trials. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[58]  L. Kessler,et al.  Factors associated with surgical and radiation therapy for early stage breast cancer in older women. , 1996, Journal of the National Cancer Institute.

[59]  B. Hankey,et al.  Completeness of hospital cancer case reporting from the SEER program of the national cancer institute , 1995 .

[60]  C. Round,et al.  Influence of clinician workload and patterns of treatment on survival from breast cancer , 1995, The Lancet.

[61]  S. Joslyn Racial differences in survival from breast cancer. , 1995, JAMA.

[62]  C K Redmond,et al.  Racial differences in survival from breast cancer. Results of the National Cancer Institute Black/White Cancer Survival Study. , 1994, JAMA.

[63]  G. Giles,et al.  Changes in the investigation and management of primary operable breast cancer in Victoria , 1994, The Medical journal of Australia.

[64]  A. Kaluzny,et al.  Physician and Practice Characteristics Associated With Judgments About Breast Cancer Treatment , 1994, Medical care.

[65]  B. Kohler,et al.  The Relation between Health Insurance Coverage and Clinical Outcomes among Women with Breast Cancer , 1993 .

[66]  A B Nattinger,et al.  Geographic variation in the use of breast-conserving treatment for breast cancer. , 1992, The New England journal of medicine.

[67]  J. Samet,et al.  Geographic variation in the treatment of localized breast cancer. , 1992, The New England journal of medicine.

[68]  J. Strain,et al.  Predictors of physician nonadherence to chemotherapy regimens , 1991, Cancer.

[69]  D. Kanouse,et al.  Changing practice patterns in the management of primary breast cancer: Consensus Development Program. , 1990, Health services research.

[70]  B. McNeil,et al.  Determinants of Physicians’ Preferences for Alternative Treatments in Women with Early Breast Cancer , 1987, Tumori.

[71]  Thomas J. Smith,et al.  Variation in staging and treatment of local and regional breast cancer in the elderly , 2005, Breast Cancer Research and Treatment.

[72]  P. Ravdin,et al.  Decision-making in early breast cancer: guidelines and decision tools. , 2002, European journal of cancer.

[73]  Joseph V. Simone,et al.  Ensuring Quality Cancer Care , 1999 .

[74]  V. Goel,et al.  Compliance with practice guidelines for node-negative breast cancer. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[75]  Assurance in Medicare,et al.  Medicare: A Strategy for Quality Assurance: VOLUME II Sources and Methods , 1990 .